{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:02:16Z","timestamp":1793800936349,"version":"4.6.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ymgme.2021.12.014","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T11:28:10Z","timestamp":1640258890000},"page":"3-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Stroke and stroke-like episodes in inborn errors of metabolism: Pathophysiological and clinical implications"],"prefix":"10.1016","volume":"135","author":[{"given":"Mario","family":"Mastrangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomina","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Giordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela De","family":"Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Toni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2021.12.014_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archneurol.2009.309","article-title":"Inherited metabolic disorders and stroke part 1: fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes","volume":"67","author":"Testai","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ejpn.2018.01.001","article-title":"Risk factors in childhood arterial ischaemic stroke: findings from a population-based study in Germany","volume":"22","author":"Gerstl","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2051-5960-2-13","article-title":"Mechanism of metabolic stroke and spontaneous cerebral hemorrhage in glutaric aciduria type I","volume":"2","author":"Zinnanti","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1567202052773544","article-title":"Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms","volume":"2","author":"Iizuka","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116726","article-title":"Metabolic stroke or stroke-like lesion: peculiarities of a phenomenon","volume":"412","author":"Finsterer","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/STROKEAHA.114.006283","article-title":"Cerebrovascular involvement in fabry disease: current status of knowledge","volume":"46","author":"Kolodny","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/STROKEAHA.108.526293","article-title":"Stroke in fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the fabry registry","volume":"40","author":"Sims","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0040","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","article-title":"Central nervous system involvement in Anderson-fabry disease: a clinical and MRI retrospective study","volume":"79","author":"Buechner","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13023-015-0253-6","article-title":"Recommendations for initiation and cessation of enzyme replacement therapy in patients with fabry disease: the european fabry working group consensus document","volume":"10","author":"Biegstraaten","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jocn.2019.03.064","article-title":"Fabry's disease and stroke: effectiveness of enzyme replacement therapy (ERT) in stroke prevention, a review with meta-analysis","volume":"65","author":"Sheng","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0055","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1161\/STROKEAHA.119.025528","article-title":"Magnetic resonance imaging findings related to stroke risk in japanese patients with fabry disease","volume":"50","author":"Yagita","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0060","article-title":"Stroke and fabry disease: a review of literature","volume":"12","author":"Mishra","year":"2020","journal-title":"Cureus."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0065","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.18632\/aging.102879","article-title":"GAA compound heterozygous mutations associated with autophagic impairment cause cerebral infarction in pompe disease","volume":"12","author":"Jia","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jimd.12087","article-title":"Phosphoglycerate kinase deficiency: a nationwide multicenter retrospective study","volume":"42","author":"Echaniz-Laguna","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0075","doi-asserted-by":"crossref","first-page":"2506S","DOI":"10.1093\/jn\/nxaa134","article-title":"Lessons learned from inherited metabolic disorders of sulfur-containing amino acids metabolism","volume":"150","author":"Ko\u017eich","year":"2020","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0080","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0085","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000127914.94292.76","article-title":"Homocysteine enhances endothelial apoptosis via upregulation of fas-mediated pathways","volume":"43","author":"Suhara","year":"2004","journal-title":"Hypertension"},{"issue":"867","key":"10.1016\/j.ymgme.2021.12.014_bb0090","article-title":"The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art","volume":"20","author":"Esse","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12272-018-1016-4","article-title":"Causes of hyperhomocysteinemia and its pathological significance","volume":"41","author":"Kim","year":"2018","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2000-8100","article-title":"Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy","volume":"26","author":"Yap","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0105","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2016.10.023","article-title":"Relation of serum homocysteine levels to cerebral artery calcification and atherosclerosis","volume":"254","author":"Kim","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.0000000000000720","article-title":"Homocysteine, small-vessel disease, and atherosclerosis an MRI study of 825 stroke patients","volume":"83","author":"Jeon","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-016-9991-4","article-title":"Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency","volume":"40","author":"Huemer","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0125","first-page":"102","article-title":"Outcomes of patients with cobalamin C deficiency: a single center experience","volume":"57","author":"Bourque","year":"2020","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2021.12.014_bb0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jimd.12041","article-title":"Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: data from the E-HOD registry","volume":"42","author":"Huemer","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.129976","article-title":"The evolving genetic landscape of congenital disorders of glycosylation","volume":"1865","author":"Wilson","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0140","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.braindev.2008.03.012","article-title":"Different neuroradiological findings during two stroke-like episodes in a patient with a congenital disorder of glycosylation type Ia","volume":"31","author":"Ishikawa","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0883073819833543","article-title":"Unusual presentation of PMM2-congenital disorder of glycosylation with isolated stroke-like episodes in a young girl","volume":"34","author":"Farmania","year":"2019","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0150","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ymgme.2007.11.006","article-title":"Risk assessment of acute vascular events in congenital disorder of glycosylation type ia","volume":"93","author":"Arnoux","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0155","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/ijms19020619","article-title":"Stroke-like episodes and cerebellar syndrome in phosphomannomutase deficiency (PMM2-CDG): evidence for hypoglycosylation-driven channelopathy","volume":"19","author":"Izquierdo-Serra","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0160","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00018-016-2357-0","article-title":"Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells","volume":"74","author":"Kaljas","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0165","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0170","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0175","first-page":"111","article-title":"Stroke as initial manifestation of adenosine deaminase 2 deficiency","volume":"48","author":"Elbracht","year":"2017","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0180","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/kev439","article-title":"Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations","volume":"55","author":"Van Montfrans","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jimd.12254","article-title":"Organic acidurias: major gaps, new challenges, and a yet unfulfilled promise","volume":"44","author":"Dimitrov","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0190","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0022-3476(88)80574-2","article-title":"Acute extrapyramidal syndrome in methylmalonic acidemia: \"Metabolic stroke\" involving the globus pallidus","volume":"113","author":"Heidenreich","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3476(89)80867-4","article-title":"Metabolic stroke in methylmalonicacidemia","volume":"115","author":"Thompson","year":"1989","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2021.12.014_bb0200","article-title":"Metabolic strokes in propionic acidemia: transient hemiplegic events without encephalopathy","volume":"3","author":"Almuqbil","year":"2019","journal-title":"Child Neurol. Open"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-0029-1231065","article-title":"Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation","volume":"40","author":"Haberlandt","year":"2009","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0210","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archneur.1984.04050230079025","article-title":"Cerebellar hemorrhage complicating methylmalonic and propionic acidemia","volume":"41","author":"Dave","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12311-009-0103-y","article-title":"Cerebellar hemorrhage in a patient with propionic acidemia","volume":"8","author":"Velasco-S\u00e1nchez","year":"2009","journal-title":"Cerebellum."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0220","doi-asserted-by":"crossref","first-page":"S473","DOI":"10.1007\/s00247-015-3279-y","article-title":"Neurometabolic diseases of childhood","volume":"45","author":"Patay","year":"2015","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0225","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/BF01396200","article-title":"Subdural hemorrhage as an initial sign of glutaric aciduria type 1: a diagnostic pitfall","volume":"26","author":"Woelfle","year":"1996","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0230","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1007\/BF02138786","article-title":"Neurological manifestations of organic acid disorders","volume":"153","author":"Hoffmann","year":"1994","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0960-8966(92)90045-8","article-title":"Melas: an original case and clinical criteria for diagnosis","volume":"2","author":"Hirano","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0240","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1590\/0004-282X20150154","article-title":"When should MELAS (Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) be the diagnosis?","volume":"73","author":"Lorenzoni","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0245","first-page":"619","article-title":"Taro matsuoka for MELAS study Group in Japan. MELAS: a nationwide prospective cohort study of 96 patients in Japan","volume":"2012","author":"Yatsuga","year":"1820","journal-title":"Biochim. Biophys. Acta"},{"issue":"59","key":"10.1016\/j.ymgme.2021.12.014_bb0250","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/WNL.59.6.816","article-title":"Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome","volume":"24","author":"Iizuka","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00688185","article-title":"Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy","volume":"74","author":"Ohama","year":"1987","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mrfmmm.2005.02.002","article-title":"Distinct nuclear gene expression profiles in cells with mtDNA depletion and homoplasmic A3243G mutation","volume":"578","author":"Jahangir Tafrechi","year":"2005","journal-title":"Mutat. Res."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.12.014_bb0265","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jns.2007.01.040","article-title":"Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS - implication of neurovascular cellular mechanism","volume":"257","author":"Iizuka","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jns.2019.03.021","article-title":"Mitochondrial metabolic stroke: phenotype and genetics of stroke-like episodes","volume":"400","author":"Finsterer","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0275","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/neup.12593","article-title":"Increased number of mitochondria in capillaries distributed in stroke-like lesions of two patients with MELAS","volume":"39","author":"Yamadera","year":"2019","journal-title":"Neuropathology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0280","first-page":"17","article-title":"Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes","volume":"23","author":"Ikawa","year":"2020","journal-title":"Curr. Opin Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0285","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/01.STR.25.9.1873","article-title":"Cerebral hyperemia in MELAS","volume":"25","author":"Gropen","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0290","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.0000000000000169","article-title":"Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers","volume":"82","author":"Weiduschat","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0295","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/ane.13027","article-title":"MELAS: monitoring treatment with magnetic resonance spectroscopy","volume":"139","author":"Hovsepian","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0300","doi-asserted-by":"crossref","first-page":"201","DOI":"10.12688\/wellcomeopenres.15599.1","article-title":"Consensus-based statements for the management of mitochondrial stroke-like episodes","volume":"4","author":"Ng","year":"2019","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0305","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.ensci.2020.100249","article-title":"Acute management of a stroke-like episode in MELAS syndrome: what should we know?","volume":"20","author":"Gonz\u00e1lez-Pinto Gonz\u00e1lez","year":"2020","journal-title":"eNeurologicalSci"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0310","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1212\/WNL.58.5.827","article-title":"Effects of L-arginine on the acute phase of strokes in three patients with MELAS","volume":"58","author":"Koga","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0315","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"L-arginine improves the symptoms of strokelike episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0320","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","article-title":"Endothelial dysfunction in MELAS improved by l-arginine supplementation","volume":"66","author":"Koga","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0325","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbagen.2011.09.005","article-title":"Molecular pathology of MELAS and L-arginine effects","volume":"1820","author":"Koga","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0330","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00415-018-9057-7","article-title":"Therapeutic regimen of L-arginine for MELAS: 9-year, prospective, multicenter, clinical research","volume":"265","author":"Koga","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0335","first-page":"5","article-title":"Arginine and citrulline for the treatment of MELAS syndrome","author":"El-Hattab","year":"2017","journal-title":"J. Inborn Errors Metab. Screening"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0340","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.braindev.2004.01.006","article-title":"Beneficial effect of L-arginine for stroke-like episode in MELAS","volume":"26","author":"Kubota","year":"2004","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238224","article-title":"L-arginine effects on cerebrovascular reactivity, perfusion and neurovascular coupling in MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) syndrome","volume":"15","author":"Rodan","year":"2020","journal-title":"PloS one"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0350","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp-2018-317964","article-title":"& KN01 Study Group. Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial","volume":"90","author":"Ohsawa","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2377-13-8","article-title":"POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome","volume":"13","author":"Cheldi","year":"2013","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0360","first-page":"89","article-title":"Stroke and stroke-like symptoms in patients with mutations in the POLG1 gene","volume":"1","author":"Brinjikji","year":"2011","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0365","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1172-9-52","article-title":"A multicenter study on Leigh syndrome: disease course and predictors of survival","volume":"9","author":"Sofou","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0370","first-page":"455","article-title":"Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis","volume":"1","author":"Yamada","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0375","article-title":"Report of the largest Chinese cohort with SLC19A3 gene defect and literature review","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0380","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/archneurol.2009.333","article-title":"Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders","volume":"67","author":"Testai","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0385","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10545-006-0194-2","article-title":"Two cases of citrullinaemia presenting with stroke","volume":"29","author":"Choi","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0390","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00431-002-1135-1","article-title":"Acute extrapyramidal syndrome in mild ornithine transcarbamylase deficiency: metabolic stroke involving the caudate and putamen without metabolic decompensation","volume":"162","author":"Keegan","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0395","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-2007-973705","article-title":"Metabolic stroke in carbamyl phosphate synthetase deficiency","volume":"28","author":"Sperl","year":"1997","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ymgme.2021.12.014_bb0400","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(05)83432-8","article-title":"Ornithine transcarbamylase deficiency presenting with strokelike episodes","volume":"122","author":"Christodoulou","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0405","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0883073814535490","article-title":"Ornithine transcarbamylase deficiency presenting with acute reversible cortical blindness","volume":"30","author":"Prasun","year":"2015","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0410","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/B978-0-444-59565-2.00046-0","article-title":"Defects in amino acid catabolism and the urea cycle","volume":"113","author":"Hoffmann","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0415","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0420","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/mdc3.12897","article-title":"Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features","volume":"7","author":"Galosi","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"23","key":"10.1016\/j.ymgme.2021.12.014_bb0425","first-page":"113","article-title":"Metabolic Stroke: A Novel Presentation in a Child with Succinic Semialdehyde Dehydrogenase Deficiency","volume":"2020","author":"Yoganathan","year":"2020","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0430","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00381-015-2942-9","article-title":"A case of acute onset succinic semialdehyde dehydrogenase deficiency: neuroimaging findings and literature review","volume":"32","author":"Wang","year":"2016","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0435","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2014.10.019","article-title":"An atypical case of Canavan disease with stroke-like presentation","volume":"52","author":"Delaney","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2021.12.014_bb0440","article-title":"Metabolic stroke-like episode in a child with FARS2 mutation and SARS-CoV-2 positive cerebrospinal fluid","volume":"27","author":"Powers","year":"2021","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221011999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221011999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:02Z","timestamp":1761090662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221011999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1096719221011999"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stroke and stroke-like episodes in inborn errors of metabolism: Pathophysiological and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}